| Mr Rafael Villalobos, DO | |
|
1151 Bethel Rd Ste 101, Columbus, OH 43220-2775 | |
| (614) 457-7772 | |
| (614) 326-2639 |
| Full Name | Mr Rafael Villalobos |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 33 Years |
| Location | 1151 Bethel Rd Ste 101, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508946518 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 34005536 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth Mansfield Hospital | Mansfield, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mansfield Plastic Surgery, Llc | 4486707932 | 2 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune diseases, and sepsis.
UPS and Merck, known as MSD outside the United States and Canada, today announced that the companies have significantly broadened their existing distribution and logistics agreement to include aspects of Merck's global supply chain around the world.
The Los Angeles Times: Although healthcare has been one of the most reliable "generators of new jobs in California," the situation is changing. A "lousy economy has caught up with an industry once considered virtually immune to downturns. The sector, which employs about 1 in 10 Californians, has stalled at a time when healthcare employment continues to grow nationally.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.
› Verified 5 days ago
| Entity Name | Mansfield Plastic Surgery, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417191636 PECOS PAC ID: 4486707932 Enrollment ID: O20090730000261 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune diseases, and sepsis.
UPS and Merck, known as MSD outside the United States and Canada, today announced that the companies have significantly broadened their existing distribution and logistics agreement to include aspects of Merck's global supply chain around the world.
The Los Angeles Times: Although healthcare has been one of the most reliable "generators of new jobs in California," the situation is changing. A "lousy economy has caught up with an industry once considered virtually immune to downturns. The sector, which employs about 1 in 10 Californians, has stalled at a time when healthcare employment continues to grow nationally.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Rafael Villalobos, DO 1151 Bethel Rd Ste 101, Columbus, OH 43220-2775 Ph: (614) 457-7772 | Mr Rafael Villalobos, DO 1151 Bethel Rd Ste 101, Columbus, OH 43220-2775 Ph: (614) 457-7772 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune diseases, and sepsis.
UPS and Merck, known as MSD outside the United States and Canada, today announced that the companies have significantly broadened their existing distribution and logistics agreement to include aspects of Merck's global supply chain around the world.
The Los Angeles Times: Although healthcare has been one of the most reliable "generators of new jobs in California," the situation is changing. A "lousy economy has caught up with an industry once considered virtually immune to downturns. The sector, which employs about 1 in 10 Californians, has stalled at a time when healthcare employment continues to grow nationally.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.
› Verified 5 days ago
Dr. Aditya Sood, M.D., M.B.A. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd Ste 2140, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Kim A. Bjorklund, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 555 S 18th St, Columbus, OH 43205 Phone: 614-722-6200 | |
Patrick W Harbour, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 915 Olentangy River Rd Ste 2140, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Kerry-ann Stewart Mitchell, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Cristiane M. Ueno, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Gan Hok Bing, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3600 Olentangy River Rd Ste 480, Columbus, OH 43214 Phone: 614-457-2233 Fax: 614-457-3012 | |
Dexter W Blome, M.D., PH.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 85 Mcnaughten Rd, Suite 260, Columbus, OH 43213 Phone: 614-755-4155 Fax: 614-755-5104 |